Standout Papers
Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients
2015
Development of Cellular Immune Responses against PAX5, a Novel Target for Cancer Immunotherapy
2008
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Application of artificial neural networks for automated analysis of cystoscopic images: a review of the current status and future prospects
2020
A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis
2019 Standout
Circular RNA expression is abundant and correlated to aggressiveness in early-stage bladder cancer
2017
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma
2014
Early repeated ureteroscopy within 6–8 weeks after a primary endoscopic treatment in patients with upper tract urothelial cell carcinoma: preliminary findings
2015
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
2017 Standout
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial
2016
Use of Vesical Imaging-Reporting and Data System (VI-RADS) for detecting the muscle invasion of bladder cancer: a diagnostic meta-analysis
2020
Repeat Transurethral Resection in Non–muscle-invasive Bladder Cancer: A Systematic Review
2018
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Urine markers for detection and surveillance of bladder cancer
2013
Automated Detection and Grading of Non–Muscle-Invasive Urothelial Cell Carcinoma of the Bladder
2020
A deep learning algorithm using CT images to screen for Corona virus disease (COVID-19)
2021 Standout
Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach
2015
Grading of Urothelial Carcinoma and The New “World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016”
2018
Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer
2016
The past, present and future of cystoscopy: the fusion of cystoscopy and novel imaging technology
2008
Macrophages in immunoregulation and therapeutics
2023 Standout
A meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancer
2017
A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging
2015
Narrow band imaging diagnosis of bladder cancer: systematic review and meta‐analysis
2012
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
2017 Standout
Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysis
2011
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
2017 Standout
Utilization of Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages
2018
Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer
2016
The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer
2007
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa–pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
2015
Photodynamic Diagnosis in Urology: State-of-the-Art
2007
Image-guided cancer surgery using near-infrared fluorescence
2013 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Pyroptosis: mechanisms and diseases
2021 Standout
Hexaminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis and Follow-Up of Patients with Non–Muscle-Invasive Bladder Cancer: Review of the Evidence and Recommendations
2010
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
2016 Standout
Assessing the value of diagnostic tests: a framework for designing and evaluating trials
2012
EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
2013
Detection and clinical outcome of urinary bladder cancer with 5‐aminolevulinic acid‐induced fluorescence cystoscopy
2010
Bladder cancer
2016 Standout
Deep learning in histopathology: the path to the clinic
2021 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers
2012
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Diagnostic biomarkers in non-muscle invasive bladder cancer
2018
Seguimiento oncológico después de cistectomía radical basado en patrones de recidiva tumoral y sus factores de riesgo
2013
Photodynamic Diagnosis in Non–Muscle-Invasive Bladder Cancer: A Systematic Review and Cumulative Analysis of Prospective Studies
2009
Sarcopenia
2019 Standout
Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice
2023
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
2021 Standout
Current and future burden of breast cancer: Global statistics for 2020 and 2040
2022 Standout
The biogenesis, biology and characterization of circular RNAs
2019 Standout
Mechanisms of BCG immunotherapy and its outlook for bladder cancer
2018
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus
2014
Photodynamic Diagnosis of Non–muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data
2013
Transurethral Resection of Non–Muscle-Invasive Bladder Transitional Cell Cancers With or Without 5-Aminolevulinic Acid Under Visible and Fluorescent Light: Results of a Prospective, Randomised, Multicentre Study
2009
EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin
2015
Hepatocellular carcinoma
2022 Standout
Oncological and functional outcomes of sexual function–preserving cystectomy compared with standard radical cystectomy in men: A systematic review
2017
Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency
2017
Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer
2021
LONG-TERM BENEFIT OF 5-AMINOLEVULINIC ACID FLUORESCENCE ASSISTED TRANSURETHRAL RESECTION OF SUPERFICIAL BLADDER CANCER: 5-YEAR RESULTS OF A PROSPECTIVE RANDOMIZED STUDY
2005
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer
2018
Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette‐Guérin
2009
Current states and future views in photodynamic therapy
2011
Reply to Anna Orsola, Lluís Cecchini and Juan Morote's Letter to the Editor re: Marko Babjuk, Willem Oosterlinck, Richard Sylvester, et al. EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder. Eur Urol 2008;54:303–14
2008
Bladder Cancer
2020 Standout
The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial update
2014
The Paris System for Reporting Urinary Cytology
2015
Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy
2016
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Follow-up after radical cystectomy based on patterns of tumor recurrence and its risk factors
2013
Cancer statistics for the year 2020: An overview
2021 Standout
A Phase III, Multicenter Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Superficial Papillary Lesions in Patients With Bladder Cancer
2007
Quality of diagnostic staging in patients with bladder cancer: A process‐outcomes link
2014
Can AI Help in Screening Viral and COVID-19 Pneumonia?
2020 Standout
Long-Term Decrease in Bladder Cancer Recurrence with Hexaminolevulinate Enabled Fluorescence Cystoscopy
2012
Cancer treatment and survivorship statistics, 2019
2019 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma
2016
Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non–Muscle-Invasive Bladder Cancer on Tumor Recurrence
2018
Works of Viktor Soukup being referenced
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Urinary Cytology and Quantitative BTA and UBC Tests in Surveillance of Patients with pTapT1 Bladder Urothelial Carcinoma
2008
Narrow Band Imaging Cystoscopy Improves the Detection of Non–muscle-invasive Bladder Cancer
2010
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
2019
Association of PAX5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder
2006
Analysis of genetic events in 17p13 and 9p21 regions supports predominant monoclonal origin of multifocal and recurrent bladder cancer
2005
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
2021
Does the Expression of Fascin-1 and Tumor Subclassification Help to Assess the Risk of Recurrence and Progression in T1 Urothelial Urinary Bladder Carcinoma?
2008
5‐aminolaevulinic acid‐induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer
2005
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review
2017
Follow-up After Surgical Treatment of Bladder Cancer: A Critical Analysis of the Literature
2012
487 5-Aminolevulinic acid induced fluorescence cystoscopy reduces the risk of early recurrence after transurethral resection of superficial bladder tumours. Results of prospective randomized trial
2004